GENE SIGNATURE TO PREDICT HOMOLOGOUS RECOMBINATION (HR) DEFICIENT CANCER
申请(专利)号：
14/772549
申请日期：
03/04/2014
公开/公告号：
US20160010159
申请(专利权)人：
国省代号：
WO
摘要：
Methods for identifying and treating cancers that are homologous recombination (HR)-repair defective. In some aspects, HR defective cancers are treated with a PARP inhibitor therapy. Methods for sensitizing cancers to a PARP inhibitor therapy are also provided.
展开
通过文献互助平台发起求助，成功后即可免费获取论文全文。
请先登入
相似文献
参考文献
引证文献
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
